- ORCID iD
-
0000-0001-8879-1772
Show
Sort by
-
- Conference Paper
- C3
- open access
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors
-
Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model
-
- Journal Article
- A1
- open access
Perihematomal changes in glucose metabolism and cell counts in the rat collagenase model for intracerebral hemorrhage
-
- Journal Article
- A1
- open access
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs
-
- Conference Paper
- C3
- open access
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
-
- Journal Article
- A1
- open access
The pan-PPAR agonist lanifibranor reduces portal pressure independent of fibrosis reduction through the splanchnic vasculature
-
Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
Metabolic brain connectivity using 18F-FDG PET imaging in the rat collagenase model
-
Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma
-
- Journal Article
- A2
- open access
Generation of post-surgical minimal residual disease models to investigate metastasis in soft tissue sarcoma patient-derived orthotopic xenografts